Bionomics Operating Margin from 2010 to 2024
| BNOX Stock | USD 0.28 0.02 6.67% |
Check Bionomics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bionomics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 412.7 K, Interest Expense of 19 K or Other Operating Expenses of 18.8 B, as well as many indicators such as Price To Sales Ratio of 152.7 K, Dividend Yield of 0.0 or PTB Ratio of 0.37. Bionomics financial statements analysis is a perfect complement when working with Bionomics Valuation or Volatility modules.
Bionomics | Operating Margin |
Latest Bionomics' Operating Margin Growth Pattern
Below is the plot of the Operating Profit Margin of Bionomics Ltd ADR over the last few years. It is Bionomics' Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bionomics' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 89.10 % | 10 Years Trend |
|
Operating Profit Margin |
| Timeline |
Bionomics Operating Margin Regression Statistics
| Arithmetic Mean | (369.25) | |
| Coefficient Of Variation | (191.29) | |
| Mean Deviation | 543.38 | |
| Median | (2.02) | |
| Standard Deviation | 706.35 | |
| Sample Variance | 498,928 | |
| Range | 1.8K | |
| R-Value | (0.73) | |
| Mean Square Error | 253,119 | |
| R-Squared | 0.53 | |
| Significance | 0 | |
| Slope | (114.87) | |
| Total Sum of Squares | 7M |
Bionomics Operating Margin History
About Bionomics Financial Statements
Bionomics investors use historical fundamental indicators, such as Bionomics' Operating Margin, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Bionomics. Please read more on our technical analysis and fundamental analysis pages.
Bionomics Limited, a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers. Bionomics Limited was incorporated in 1996 and is based in Eastwood, Australia. Bionomics is traded on NASDAQ Exchange in the United States.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Bionomics Stock Analysis
When running Bionomics' price analysis, check to measure Bionomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bionomics is operating at the current time. Most of Bionomics' value examination focuses on studying past and present price action to predict the probability of Bionomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bionomics' price. Additionally, you may evaluate how the addition of Bionomics to your portfolios can decrease your overall portfolio volatility.